» Articles » PMID: 24494041

The Relevance of the Vitamin D Endocrine System (VDES) for Tumorigenesis, Prevention, and Treatment of Non-melanoma Skin Cancer (NMSC): Present Concepts and Future Perspectives

Overview
Specialty Endocrinology
Date 2014 Feb 5
PMID 24494041
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Solar UV (UV)-B-radiation exerts both beneficial and adverse effects on human health. On the one hand, it is the most important environmental risk factor for the development of non-melanoma skin cancer [NMSC; most importantly basal (BCC) and squamous (SCC) cell carcinomas], that represent the most common malignancies in Caucasian populations. On the other hand, the human body's requirements of vitamin D are mainly achieved by UV-B-induced cutaneous photosynthesis. This dilemma represents a serious problem in many populations, for an association of vitamin D-deficiency and multiple independent diseases including various types of cancer has been convincingly demonstrated. In line with these findings, epidemiologic and laboratory investigations now indicate that vitamin D and its metabolites have a risk reducing effect for NMSC. Potential mechanisms of action include inhibition of the hedgehog signaling pathway (BCC) and modulation of p53-mediated DNA damage response (SCC). As a consequence of these new findings it can be concluded that UV-B-radiation exerts both beneficial and adverse effects on risk and prognosis of NMSC. It can be assumed that many independent factors, including frequency and dose of UV-B exposure, skin area exposed, and individual factors (such as skin type and genetic determinants of the skin`s vitamin D status and of signaling pathways that are involved in the tumorigenesis of NMSC) determine whether UV-B exposure promotes or inhibits tumorigenesis of NMSC. Moreover, these findings may help to explain many of the differential effects of UV-B radiation on risk of NMSC, including variation in the dose-dependent risk for development of SCC in situ (actinic keratosis, AK), invasive SCC, and BCC. In this review, we analyze the relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of NMSC and give an overview of present concepts and future perspectives.

Citing Articles

A study on the global burden of non-melanoma skin cancer from 1990 to 2019.

Si Z, Ying J, Zhou Y Arch Med Sci. 2025; 20(6):1902-1908.

PMID: 39967956 PMC: 11831353. DOI: 10.5114/aoms/187003.


Pan-Cancer Analysis Confirms the Prognostic and Immunological Implications of the 1,25-Dihydroxy Vitamin D3 Receptor in Cervical Squamous Cell Carcinoma.

Faris I, Ibrahim N, Zeanelabdeen T, Alfaki M Cureus. 2024; 16(8):e66743.

PMID: 39268267 PMC: 11391166. DOI: 10.7759/cureus.66743.


Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years.

Hu W, Fang L, Ni R, Zhang H, Pan G BMC Cancer. 2022; 22(1):836.

PMID: 35907848 PMC: 9339183. DOI: 10.1186/s12885-022-09940-3.


Serum levels of 25-hydroxy-vitamin D in patients with oral squamous cell carcinoma: Making a case for chemoprevention.

Udeabor S, Albejadi A, Al-Shehri W, Onwuka C, Al-Fathani S, Al Nazeh A Clin Exp Dent Res. 2020; 6(4):428-432.

PMID: 32246747 PMC: 7453769. DOI: 10.1002/cre2.294.


Relevance of Vitamin D in Melanoma Development, Progression and Therapy.

Brozyna A, Hoffman R, Slominski A Anticancer Res. 2020; 40(1):473-489.

PMID: 31892603 PMC: 6948187. DOI: 10.21873/anticanres.13976.


References
1.
Han J, Colditz G, Hunter D . Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis. 2006; 28(2):390-7. DOI: 10.1093/carcin/bgl156. View

2.
Stapelberg M, Williams R, Byrne S, Halliday G . The alternative complement pathway seems to be a UVA sensor that leads to systemic immunosuppression. J Invest Dermatol. 2009; 129(11):2694-701. DOI: 10.1038/jid.2009.128. View

3.
Kvam E, Tyrrell R . Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation. Carcinogenesis. 1998; 18(12):2379-84. DOI: 10.1093/carcin/18.12.2379. View

4.
Donehower L, Harvey M, Slagle B, McArthur M, Montgomery Jr C, Butel J . Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992; 356(6366):215-21. DOI: 10.1038/356215a0. View

5.
Mullauer L, Gruber P, Sebinger D, Buch J, Wohlfart S, Chott A . Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res. 2001; 488(3):211-31. DOI: 10.1016/s1383-5742(01)00057-6. View